[PDF][PDF] ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

JI Wolfsdorf, N Glaser, M Agus, M Fritsch… - Pediatric …, 2018 - edisciplinas.usp.br
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the
hyperglycemic hyperosmolar state Page 1 ISPAD CLINICAL PRACTICE CONSENSUS …

Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis

CA Andrade‐Castellanos… - Cochrane Database …, 2016 - cochranelibrary.com
Background Diabetic ketoacidosis (DKA) is an acute, life‐threatening complication of
uncontrolled diabetes that mainly occurs in individuals with autoimmune type 1 diabetes, but …

[PDF][PDF] ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes.

E Cengiz, T Danne, T Ahmad, A Ayyavoo… - Pediatric …, 2022 - researchgate.net
ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and
adolescents with diabetes Page 1 ISPAD GUIDELINES ISPAD Clinical Practice Consensus …

Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies

M Vincent, E Nobécourt - Diabetes & metabolism, 2013 - Elsevier
Aim Low-dose intravenous infusions of regular insulin, usually initiated in the emergency
department and continued in the intensive care unit (ICU), are the standard care for patients …

Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients

Z Razavi, S Maher, J Fredmal - Endocrine, 2018 - Springer
Purpose To compare the safety/efficacy of intermittent subcutaneous rapid-acting insulin
aspart with the standard low-dose intravenous infusion protocol of regular insulin for …

Managing diabetic ketoacidosis in non-intensive care unit setting: role of insulin analogs

R Karoli, J Fatima, T Salman, S Sandhu… - Indian Journal of …, 2011 - journals.lww.com
Aim: To compare the efficacy and safety of rapid acting insulin analog lispro given
subcutaneously with that of standard low-dose intravenous regular insulin infusion …

[HTML][HTML] Diabetic ketoacidosis: treatment in the intensive care unit or general medical/surgical ward?

Y Mendez, S Surani, J Varon - World journal of diabetes, 2017 - ncbi.nlm.nih.gov
Diabetic ketoacidosis (DKA) is defined as an acute metabolic disorder, which is
characterized by an increased presence of circulating ketones, and the development of …

[HTML][HTML] Frequency and associated risk factors of recurrent diabetic ketoacidosis among Saudi adolescents with type 1 diabetes mellitus

AA Al-Hayek, AA Robert, RB Braham… - Saudi Medical …, 2015 - ncbi.nlm.nih.gov
Objectives: To explore the frequency and associated risk factors of recurrent diabetic
ketoacidosis (RDKA) among Saudi adolescents with type 1 diabetes mellitus (T1DM) …

Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children

M Cohen, N Leibovitz, S Shilo… - Pediatric …, 2017 - Wiley Online Library
Background Diabetic ketoacidosis (DKA) treatment protocols vary, however low‐dose
intravenous administration of regular insulin is the standard care for replacing insulin in most …

Factors associated with the presence of diabetic ketoacidosis: A retrospective analysis of patients with type 1 diabetes in Saudi Arabia

AA Al Hayek, AA Robert, ALS Ruqayah… - Diabetes & Metabolic …, 2020 - Elsevier
Abstract Background and aims To Investigate the factors associated with Diabetic
Ketoacidosis (DKA) among patients with type 1 diabetes (T1D). Methods This was a …